A Modified Injector and Sample Acquisition Protocol Can Improve Data Quality and Reduce Inter-Instrument Variability of the Helios Mass Cytometer
Brian H. Lee(Icahn School of Medicine at Mount Sinai), Adeeb Rahman(Immunai (United States)), Alessandro Sette(La Jolla Institute for Immunology), Ruth R. Montgomery(Fred Hutch Cancer Center), Yuan Tian(La Jolla Institute for Immunology), Bjoern Peters(La Jolla Institute for Immunology), John S. Tsang(Yale University), Brian A. Sellers, Xinzheng V. Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Melanie Davila(Icahn School of Medicine at Mount Sinai), Minnie Sarwal(Stanford University), Joanne Lannigan(National Institutes of Health), Tara K. Sigdel(City College of San Francisco), Julián Candia(National Institutes of Health), Emily M. Thrash(Dana-Farber Cancer Institute), Geoffrey Kelly(Icahn School of Medicine at Mount Sinai), El-ad David Amir(Icahn School of Medicine at Mount Sinai), Shermineh Bradford(Icahn School of Medicine at Mount Sinai), Stanley Tamaki(University of California, San Francisco), Denise Hinz(La Jolla Institute for Immunology), Cheryl Kim(La Jolla Institute for Immunology), Michael D. Solga(University of Virginia Health System), Lewis L. Lanier(Universidad Católica de Santa Fe)
Cited by 2
Related Papers
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k